Favipiravir‐induced nephrotoxicity in a patient with COVID‐19: A case report |
| |
| Authors: | Asmaa A. Abdelbary Ahmad E. Alharafsheh Afif Ahmed Abdulqadir J. Nashwan |
| |
| Affiliation: | 1. Pharmacy Department, Home Health Care Services (HHCS), Hamad Medical Corporation, Doha Qatar ; 2. Pharmacy Department, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha Qatar ; 3. Corporate Pharmacy Department, Hamad Medical Corporation (HMC), Doha Qatar ; 4. Nursing Department, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha Qatar |
| |
| Abstract: | This report describes a case of 45 years old male patient who tested positive for COVID‐19 presented to the emergency department on March 2021 complaining of fever, cough, runny nose, and shortness of breath. The patient denied any history of nausea or diarrhea who has eventually developed favipiravir‐induced nephrotoxicity. |
| |
| Keywords: | acute kidney injury, COVID‐ 19, favipiravir, nephrotoxicity |
|
|
